← All trials
NCT04442295
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 3, 2020
- Primary completion
- Sep 11, 2021
- Completion date
- Oct 8, 2022
- First posted
- Jun 22, 2020
- Last posted
- Dec 21, 2020
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Stoke Therapeutics, IncLead sponsor
- InnovadermStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.